Menu
Enrolling by invitation NCT07297862

Virtual Reality Sickness Questionnaire: Psychometrics in Stroke Patients

— Observational Motion Sickness

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Roller Coaster application.
Who it may be relevant to
Registry conditions: Motion Sickness. Basic parameters: 18 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Investigation of the Psychometric Properties of the Virtual Reality Sickness Questionnaire in Stroke Patients

Overview

The aim of this study is to examine the effects of virtual reality on physiological factors (heart rate, blood pressure) in stroke patients and the psychometric properties of the Virtual Reality Sickness Questionnaire in assessing Motion Sickness resulting from virtual reality use.

Detailed description

Despite the proven advantages of virtual reality approximately 30% of users report nausea and up to 40% experience eye strain as a result of prolonged exposure to virtual environments and simulators. These problems are referred to as motion sickness (MS) a side effect of virtual reality use.

The Motion Sickness Assessment Questionnaire (MSAQ) and the Simulator Sickness Questionnaire (SSQ), which evaluates the symptoms under four titles (gastrointestinal, central, peripheral and fatigue), are used in the literature to evaluate this effect. However, these questionnaires may not be sufficient to assess the MS symptoms that develop after virtual reality (VR) applications. Because MS symptoms occur differently in VR and simulation systems. For this reason, the Virtual Reality Sickness Questionnaire (VRSQ) was developed by Kim and his colleagues to evaluate the symptoms that occur after virtual reality. The Turkish validity and reliability of the VRSQ, which consists of 9 questions, was also conducted by Cetin and his friends.

The aim of this study to investigate how virtual reality affects physiological factors (heart rate, blood pressure) in stroke patients and to evaluate the psychometric properties of the Virtual Reality Sickness Questionnaire in assessing VR-induced motion sickness.

Interventions

  • Other Roller Coaster application
    Participants will experience a 15-minute roller coaster virtual reality (VR) for three consecutive days, once a day. During this study, the virtual reality application will be performed while sitting in a chair and while fixed to the chair. The practitioner will be present with the participant throughout the VR application.

Primary outcome measures

  • Virtual Reality Sickness Questionnaire [Time frame: immediately after roller coaster application]
Secondary outcome measures (8)
  • Titmus Test [Time frame: Baseline]
  • National Institutes of Health Stroke Scale (NIHSS) [Time frame: Baseline]
  • Standardized Mini Mental Test (SMMT) [Time frame: Baseline]
  • The Motion Sensitivity Test (MST) [Time frame: immediately after roller coaster application]
  • Tolerance Period [Time frame: During application]
  • Heart Rate [Time frame: baseline and immediately after roller coaster application]
  • Feeling of discomfort [Time frame: immediately after roller coaster application]
  • Blood Pressure [Time frame: baseline and immediately after roller coaster application]

Eligibility criteria

Inclusion criteria for individuals with stroke:

  • Stroke diagnosis,
  • A minimum score of 24 on the Standardised Mini Mental Test (SMMT), 2.18-80 years old,
  • showing symptoms of MS with a minimum score of 10 on the Virtual Reality Sickness Questionnaire
  • Titmus test result of 3552 arc/s
  • Not having neglect syndrome

Exclusion criteria

  • Not volunteering for the study,
  • Presence of a diagnosis of neurological disease other than stroke,
  • Presence of a history of previous stroke,
  • Complete or partial loss of vision in one eye,
  • Previous use of Virtual Reality
  • Having diseases affecting the vestibular system such as Vertigo, Benign Paroxysmal Vertigo, Meniere's

Inclusion criteria for Healthy Individuals:

1\. A minimum score of 24 on the Standardised Mini Mental Test (SMMT), 2.18-80 years old, 3. showing symptoms of MS with a minimum score of 10 on the Virtual Reality Sickness Questionnaire 4. Titmus test result of 3552 arc/s

Exclusion criteria

  • Not volunteering for the study,
  • Presence of a diagnosis of neurological disease,
  • Complete or partial loss of vision in one eye,
  • Previous use of Virtual Reality
  • Having diseases affecting the vestibular system such as Vertigo, Benign Paroxysmal Vertigo, Meniere's

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Case-control

Study locations

Turkey (Türkiye) · 1 center
  • Abant Izzet Baysal University — Bolu

Identifiers

NCT: NCT07297862 · AIBU-FTR-BS-001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗